AYTU
CFO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Mark Oki is recorded as CFO at Achieve Life Sciences, Inc. (ACHV) and CFO at Aytu Biopharma, Inc (AYTU). The proxy statement of Achieve Life Sciences, Inc. reports total compensation of $1,015,388 for Mark Oki in fiscal 2024, including a base salary of $30,864. Mark Oki has spoken on 14 earnings calls across 2 companies, most recently for Achieve Life Sciences, Inc. on March 24, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
AYTU
CFO
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Achieve Life Sciences, Inc. (ACHV) | Chief Financial Officer | $30,864 | $1,015,388 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.